Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
TransMedics Group, Inc.
Report date February 01, 2023 · Filed February 03, 2023
Section 16 reporting ended · disclosed 2023-02-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,120 |
Ending reported balance
After 2023-02-01 transaction · row 7
7 source rows · reconciled sequenceRow 1 · 2023-02-01 · Exercise / conversion · Acquired 1,363 · Balance 15,483 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Row 2 · 2023-02-01 · Exercise / conversion · Acquired 47 · Balance 15,530 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Row 3 · 2023-02-01 · Sale · Disposed 582 · Balance 14,948 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.23 to $62.22, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Row 4 · 2023-02-01 · Sale · Disposed 379 · Balance 14,569 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.23 to $63.02, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Row 5 · 2023-02-01 · Sale · Disposed 96 · Balance 14,473 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $63.43 to $64.41, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Row 6 · 2023-02-01 · Sale · Disposed 139 · Balance 14,334 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F5: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $64.45 to $65.42, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Row 7 · 2023-02-01 · Sale · Disposed 214 · Balance 14,120 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F6: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $65.45 to $65.96, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.14 · Expires 2030-02-27 | Direct | 4,887 |
Reported balance
After 2023-02-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2023-02-01 · Exercise / conversion · Disposed 1,363 · Balance 4,887 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F7: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.46 · Expires 2031-02-24 | Direct | 13,543 |
Reported balance
After 2023-02-01 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2023-02-01 · Exercise / conversion · Disposed 47 · Balance 13,543 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F8: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.23 to $62.22, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.23 to $63.02, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $63.43 to $64.41, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F5: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $64.45 to $65.42, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F6: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $65.45 to $65.96, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F7: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.
F8: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2023 Filed Feb 3, 2023 22:12 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 47 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000899243-23-003891 · doc4.xml · derivative · entry 9 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,543 Underlying: Common Stock · 47 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F8 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:12 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,363 | $0.00 Strike: $16.14 | $0.00 |
DisclosureSEC source: 0000899243-23-003891 · doc4.xml · derivative · entry 8 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,887 Underlying: Common Stock · 1,363 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F7 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:12 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 214 | $65.81 | $14,083.34 |
DisclosureSEC source: 0000899243-23-003891 · doc4.xml · nonDerivative · entry 7 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,120 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $65.45 to $65.96, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:12 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 139 | $64.88 | $9,018.32 |
DisclosureSEC source: 0000899243-23-003891 · doc4.xml · nonDerivative · entry 6 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,334 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $64.45 to $65.42, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:12 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 96 | $64.04 | $6,147.84 |
DisclosureSEC source: 0000899243-23-003891 · doc4.xml · nonDerivative · entry 5 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,473 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $63.43 to $64.41, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:12 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 379 | $62.52 | $23,695.08 |
DisclosureSEC source: 0000899243-23-003891 · doc4.xml · nonDerivative · entry 4 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,569 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.23 to $63.02, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:12 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 582 | $62.00 | $36,084.00 |
DisclosureSEC source: 0000899243-23-003891 · doc4.xml · nonDerivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,948 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.23 to $62.22, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:12 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 47 | $38.46 | $1,807.62 |
DisclosureSEC source: 0000899243-23-003891 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,530 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:12 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 1,363 | $16.14 | $21,998.82 |
DisclosureSEC source: 0000899243-23-003891 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,483 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 22:58 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,410 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000899243-23-002074 · doc4.xml · derivative · entry 7 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,590 Underlying: Common Stock · 1,410 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F8 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 22:58 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 114 | $64.30 | $7,330.20 |
DisclosureSEC source: 0000899243-23-002074 · doc4.xml · nonDerivative · entry 6 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,120 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $64.19 to $64.52, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F7 · balance_after: The amount of securities directly owned by the Reporting Person includes 276 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 22:58 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 449 | $63.70 | $28,601.30 |
DisclosureSEC source: 0000899243-23-002074 · doc4.xml · nonDerivative · entry 5 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,234 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $63.19 to $64.18, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F7 · balance_after: The amount of securities directly owned by the Reporting Person includes 276 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 22:58 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 338 | $62.48 | $21,118.24 |
DisclosureSEC source: 0000899243-23-002074 · doc4.xml · nonDerivative · entry 4 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,683 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.18 to $63.17, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F7 · balance_after: The amount of securities directly owned by the Reporting Person includes 276 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 22:58 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 446 | $61.77 | $27,549.42 |
DisclosureSEC source: 0000899243-23-002074 · doc4.xml · nonDerivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,021 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.18 to $62.17, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F7 · balance_after: The amount of securities directly owned by the Reporting Person includes 276 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 22:58 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 63 | $60.72 | $3,825.36 |
DisclosureSEC source: 0000899243-23-002074 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,467 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $60.12 to $61.07, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F7 · balance_after: The amount of securities directly owned by the Reporting Person includes 276 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 22:58 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 1,410 | $38.46 | $54,228.60 |
DisclosureSEC source: 0000899243-23-002074 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,530 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F7 · balance_after: The amount of securities directly owned by the Reporting Person includes 276 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. Read SEC document |
| December 05, 2022 Filed Dec 5, 2022 22:33 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 36 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-22-037665 · doc4.xml · derivative · entry 14 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option is fully vested. Read SEC document |
| December 05, 2022 Filed Dec 5, 2022 22:33 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 36 | $0.28 | $10.08 |
DisclosureSEC source: 0000899243-22-037665 · doc4.xml · nonDerivative · entry 9 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,844 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 22:33 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000899243-22-037665 · doc4.xml · derivative · entry 13 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 10,000 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 22:33 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,800 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-22-037665 · doc4.xml · derivative · entry 12 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,800 shares Expires 2023-03-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option is fully vested. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 22:33 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,237 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-22-037665 · doc4.xml · derivative · entry 11 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36 Underlying: Common Stock · 6,237 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option is fully vested. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 22:33 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 10,000 | $63.50 | $635,000.00 |
DisclosureSEC source: 0000899243-22-037665 · doc4.xml · nonDerivative · entry 8 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,808 F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $63.50 to $63.55, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 22:33 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 10,000 | $38.46 | $384,600.00 |
DisclosureSEC source: 0000899243-22-037665 · doc4.xml · nonDerivative · entry 7 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,808 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 22:33 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 6,800 | $0.28 | $1,904.00 |
DisclosureSEC source: 0000899243-22-037665 · doc4.xml · nonDerivative · entry 6 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,808 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 22:33 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 6,237 | $0.28 | $1,746.36 |
DisclosureSEC source: 0000899243-22-037665 · doc4.xml · nonDerivative · entry 5 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,008 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:33 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-22-037665 · doc4.xml · derivative · entry 10 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,273 Underlying: Common Stock · 3,000 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F5 · derivative.exercise_date: The option is fully vested. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:33 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 100 | $62.45 | $6,245.00 |
DisclosureSEC source: 0000899243-22-037665 · doc4.xml · nonDerivative · entry 4 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 771 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:33 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 1,403 | $61.70 | $86,565.10 |
DisclosureSEC source: 0000899243-22-037665 · doc4.xml · nonDerivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 871 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.29 to $61.99, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:33 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 1,497 | $60.83 | $91,062.51 |
DisclosureSEC source: 0000899243-22-037665 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,274 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $60.23 to $61.22, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:33 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 3,000 | $0.28 | $840.00 |
DisclosureSEC source: 0000899243-22-037665 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 01, 2022 Filed Nov 4, 2022 00:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-22-035001 · doc4.xml · derivative · entry 4 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,273 Underlying: Common Stock · 3,000 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| November 01, 2022 Filed Nov 4, 2022 00:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 700 | $49.58 | $34,706.00 |
DisclosureSEC source: 0000899243-22-035001 · doc4.xml · nonDerivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 771 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $49.32 to $50.22, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 01, 2022 Filed Nov 4, 2022 00:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 2,300 | $48.86 | $112,378.00 |
DisclosureSEC source: 0000899243-22-035001 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,471 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $48.32 to $49.28, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 01, 2022 Filed Nov 4, 2022 00:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 3,000 | $0.28 | $840.00 |
DisclosureSEC source: 0000899243-22-035001 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 20:31 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,216 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-22-032663 · doc4.xml · derivative · entry 6 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,273 Underlying: Common Stock · 2,216 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 20:31 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 784 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-22-032663 · doc4.xml · derivative · entry 5 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 784 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 20:31 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 680 | $42.63 | $28,988.40 |
DisclosureSEC source: 0000899243-22-032663 · doc4.xml · nonDerivative · entry 4 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 771 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $42.52 to $42.95, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 20:31 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 2,320 | $41.93 | $97,277.60 |
DisclosureSEC source: 0000899243-22-032663 · doc4.xml · nonDerivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,451 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $41.51 to $42.50, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 20:31 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 2,216 | $0.28 | $620.48 |
DisclosureSEC source: 0000899243-22-032663 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 20:31 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 784 | $2.21 | $1,732.64 |
DisclosureSEC source: 0000899243-22-032663 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 21:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-22-030305 · doc4.xml · derivative · entry 4 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,784 Underlying: Common Stock · 3,000 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 21:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 1,699 | $51.38 | $87,294.62 |
DisclosureSEC source: 0000899243-22-030305 · doc4.xml · nonDerivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 771 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $51.10 to $51.83, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 21:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 1,301 | $50.71 | $65,973.71 |
DisclosureSEC source: 0000899243-22-030305 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,470 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $50.09 to $51.00, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 21:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 3,000 | $2.21 | $6,630.00 |
DisclosureSEC source: 0000899243-22-030305 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 00:40 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-22-027258 · doc4.xml · derivative · entry 10 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,784 Underlying: Common Stock · 3,000 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F8 · derivative.exercise_date: The option is fully vested. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 00:40 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 400 | $41.84 | $16,736.00 |
DisclosureSEC source: 0000899243-22-027258 · doc4.xml · nonDerivative · entry 7 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 771 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $41.78 to $41.95, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F6 · balance_after: The amount of securities directly owned by the Reporting Person includes 392 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 00:40 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 2,200 | $41.39 | $91,058.00 |
DisclosureSEC source: 0000899243-22-027258 · doc4.xml · nonDerivative · entry 6 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,171 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $40.78 to $41.76, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F6 · balance_after: The amount of securities directly owned by the Reporting Person includes 392 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 00:40 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 400 | $40.02 | $16,008.00 |
DisclosureSEC source: 0000899243-22-027258 · doc4.xml · nonDerivative · entry 5 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,371 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $39.60 to $40.39, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F6 · balance_after: The amount of securities directly owned by the Reporting Person includes 392 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 00:40 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 3,000 | $2.21 | $6,630.00 |
DisclosureSEC source: 0000899243-22-027258 · doc4.xml · nonDerivative · entry 4 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F6 · balance_after: The amount of securities directly owned by the Reporting Person includes 392 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 00:40 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,959 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-22-027258 · doc4.xml · derivative · entry 9 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,784 Underlying: Common Stock · 1,959 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F8 · derivative.exercise_date: The option is fully vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.